Kymera COO sells $1.37m shares
Kymera Therapeutics COO sells shares worth $1.37m, potentially indicating insider activity. This may impact investor sentiment.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.